These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 30908997

  • 1. In-silico designing and characterization of binding modes of two novel inhibitors for CB1 receptor against obesity by classical 3D-QSAR approach.
    Khan N, Halim SA, Khan W, Zafar SK, Ul-Haq Z.
    J Mol Graph Model; 2019 Jun; 89():199-214. PubMed ID: 30908997
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach.
    Babu S, Sohn H, Madhavan T.
    Comput Biol Chem; 2015 Jun; 56():109-21. PubMed ID: 25935115
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA, Gadad AK.
    J Med Chem; 2006 Jan 26; 49(2):475-89. PubMed ID: 16420035
    [Abstract] [Full Text] [Related]

  • 9. 3D-QSAR studies of arylpyrazole antagonists of cannabinoid receptor subtypes CB1 and CB2. A combined NMR and CoMFA approach.
    Chen JZ, Han XW, Liu Q, Makriyannis A, Wang J, Xie XQ.
    J Med Chem; 2006 Jan 26; 49(2):625-36. PubMed ID: 16420048
    [Abstract] [Full Text] [Related]

  • 10. The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2.
    Durdagi S, Kapou A, Kourouli T, Andreou T, Nikas SP, Nahmias VR, Papahatjis DP, Papadopoulos MG, Mavromoustakos T.
    J Med Chem; 2007 Jun 14; 50(12):2875-85. PubMed ID: 17521177
    [Abstract] [Full Text] [Related]

  • 11. Combined CoMFA and CoMSIA 3D-QSAR study of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor.
    Romero-Parra J, Chung H, Tapia RA, Faúndez M, Morales-Verdejo C, Lorca M, Lagos CF, Di Marzo V, David Pessoa-Mahana C, Mella J.
    Eur J Pharm Sci; 2017 Apr 01; 101():1-10. PubMed ID: 28137469
    [Abstract] [Full Text] [Related]

  • 12. 3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data.
    Salo OM, Savinainen JR, Parkkari T, Nevalainen T, Lahtela-Kakkonen M, Gynther J, Laitinen JT, Järvinen T, Poso A.
    J Med Chem; 2006 Jan 26; 49(2):554-66. PubMed ID: 16420041
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CoMFA and CoMSIA studies on 5-hydroxyindole-3-carboxylate derivatives as 5-lipoxygenase inhibitors: generation of homology model and docking studies.
    Aparoy P, Suresh GK, Kumar Reddy K, Reddanna P.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):456-62. PubMed ID: 21084193
    [Abstract] [Full Text] [Related]

  • 16. 3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3beta inhibitors.
    Dessalew N, Patel DS, Bharatam PV.
    J Mol Graph Model; 2007 Mar 01; 25(6):885-95. PubMed ID: 17018257
    [Abstract] [Full Text] [Related]

  • 17. 3D QSAR studies, pharmacophore modeling and virtual screening on a series of steroidal aromatase inhibitors.
    Xie H, Qiu K, Xie X.
    Int J Mol Sci; 2014 Nov 14; 15(11):20927-47. PubMed ID: 25405729
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.